Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2012 Jul;60(1):88–99. doi: 10.1097/FJC.0b013e3182588b00

FIGURE 1. Activation of SkM1 and SCN5A in HEK293 cells.

FIGURE 1

(A) Expression of SkM1 or SCN5A in HEK293 cells. Na+ currents were recorded in low Na+ (15 mM) Tyrode’s solution at room temperature. Cells were held at -100 mV and then pulsed to test potentials from -80 mV to +40 mV, with a 5 mV increment. (B) Current-voltage relationship of SkM1 (n=8) and SCN5A (n=10) in HEK293 cells. Data are normalized to the maximum peak current (mean±SE). (C), (D) Study of the m gates of SkM1 and SCN5A. Data of m3 are normalized to the maximal value and fitted to the equation f=11+exp[(EmVh)/K], giving a midpoint of -21.1±0.5 mV and a slope of 5.9±0.4 mV (mean±SE, n = 8) for SkM1 (C), and a midpoint of -39.0±0.4 mV and a slope of 3.6±0.4 mV (mean±SE, n = 10) for SCN5A (D). The m curves were calculated from the curve fit.